arrow
J

Joseph Bovi

thedacare regional cancer center
H指数:26
被引数:2,755

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MULTICENTER RANDOMIZED PHASE II STUDY OF R-MPV-A CHEMOIMMUNOTHERAPY WITH OR WITHOUT LOW-DOSE WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: NRG/ RTOG 1114

多中心随机II期研究:R-MPV-A化疗免疫疗法联合或单用低剂量全脑放射治疗新诊断的原发性中枢神经系统淋巴瘤:NRG/RTOG 1114

2025-10-010
OA
Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma

Omuro, A.; DeAngelis, L.M.; Polley, M.C.; Correa, D.; Wefel, J.S.; Bovi, J.A.; Rosenblum, M.; Corn, B.W.; Aneja, S.; Grommes, C.; et al. 多中心随机II期研究:R-MPV-A化疗免疫疗法联合或不联合低剂量全脑放疗治疗新诊断的原发性中枢神经系统淋巴瘤。Neuro Oncol. 2025, noaf221. [Google Scholar] [CrossRef]

2025-10-010
PRE
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline

WHO四级成人型弥漫性胶质瘤的放射治疗:ASTRO临床实践指南

2025-06-250
PRE
A Prospective Registry Study of 68Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas
2024-03-014
OAAI
Deep Learning-Based Automatic Detection of Brain Metastases in Heterogenous Multi- Institutional Magnetic Resonance Imaging Sets: An Exploratory Analysis of NRG-CC001

基于深度学习的异质多机构磁共振成像脑转移瘤自动检测: NRG-CC001的探索性分析

2022-11-019
OAAI
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539
2022-06-0310
OA
Dose Escalated Radiation Therapy for Glioblastoma Multiforme: An International Systematic Review and Meta-Analysis of 22 Prospective Trials

剂量递增放射治疗多形性胶质母细胞瘤: 一项国际系统评价和22项前瞻性试验的荟萃分析

2021-10-0130
PREAI
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
2020-07-0137
OAAI
Significant Preservation of Neurocognitive Function (NCF) and Patient-Reported Symptoms with Hippocampal Avoidance (HA) during Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Final Results of Nrg Oncology CC001
2019-09-014
OAAI